Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term adjuvant chemotherapy. Found 19 abstracts

Del Bene G, Calabro F, Giannarelli D, Plimack ER, Harshman LC, Yu EY, Crabb SJ, Pal SK, Alva AS, Powles T, De Giorgi U, Agarwal N, Bamias A, Ladoire S, Necchi A, Vaishampayan UN, Niegisch G, Bellmunt J, Baniel J, Galsky MD, Sternberg CN, Risc Investigators. Neoadjuvant vs. Adjuvant Chemotherapy in Muscle Invasive Bladder Cancer (MIBC): Analysis From the RISC Database. Frontiers in oncology. 2018 Nov;8:463.   PMCID: PMC6252384
Mirkin KA, Hollenbeak CS, Mohamed A, Jia Y, El-Deiry WS, Messaris E. Impact of perineural invasion on survival in node negative colon cancer. Cancer Biol Ther. 2017 Sep 02;18(9):740-5.   PMCID: PMC5663408
Packel L, Fang CY, Handorf E, Rodoletz M. A 12-Week Exercise and Stress Management Pilot Program From Theory Through Implementation and Assessment. Rehabilitation Oncology. 2017 Oct;35(4):172-80.
Dawood S, Cristofanilli M. Inflammatory Breast Cancer: What Progress Have We Made?. Oncology-New York. 2011 Mar;25(3):264-73.   PMCID: not NIH funded
Dawood S, Ueno NT, Valero V, Woodward WA, Buchholz TA, Hortobagyi GN, Gonzalez-Angulo AM, Cristofanilli M. Differences in Survival Among Women With Stage III Inflammatory and Noninflammatory Locally Advanced Breast Cancer Appear Early A Large Population-Based Study. Cancer. 2011 May;117(9):1819-26.   PMCID: not NIH funded
Hyslop T, Weinberg DS, Schulz S, Barkun A, Waldman SA. Occult Tumor Burden Predicts Disease Recurrence in Lymph Node-Negative Colorectal Cancer. Clinical Cancer Research. 2011 May;17(10):3293-303.   PMCID: PMC3096730
Lara JF, Thor AD, Dressler LG, Broadwater G, Bleiweiss IJ, Edgerton S, Cowan D, Goldstein LJ, Martino S, Ingle JN, Henderson IC, Norton L, Winer EP, Hudis CA, Ellis MJ, Berry DA, Hayes DF, Canc Leukemia Grp B. p53 Expression in Node-Positive Breast Cancer Patients: Results from the Cancer and Leukemia Group B 9344 Trial (159905). Clinical Cancer Research. 2011 Aug;17(15):5170-8.   PMCID: PMC319770
O'Grady MA, Slater E, Sigurdson ER, Meropol NJ, Weinstein A, Lusch CJ, Sein E, Keeley P, Miller B, Engstrom PF, Cohen SJ. Assessing Compliance with National Comprehensive Cancer Network Guidelines for Elderly Patients with Stage III Colon Cancer: The Fox Chase Cancer Center Partners' Initiative. Clinical Colorectal Cancer. 2011 Jun;10(2):113-6.   PMCID: PMC3388796
Regine WF, Winter KA, Abrams R, Safran H, Hoffman JP, Konski A, Benson AB, Macdonald JS, Rich TA, Willett CG. Fluorouracil-based Chemoradiation with Either Gemcitabine or Fluorouracil Chemotherapy after Resection of Pancreatic Adenocarcinoma: 5-Year Analysis of the US Intergroup/RTOG 9704 Phase III Trial. Annals of Surgical Oncology. 2011 May;18(5):1319-26.   PMCID: NIHMS323431 [approved 10-18-12]
Alderman AK, Collins ED, Schott A, Hughes ME, Ottesen RA, Theriault RL, Wong YN, Weeks JC, Niland JC, Edge SB. The Impact of Breast Reconstruction on the Delivery of Chemotherapy. Cancer. 2010 Apr;116(7):1791-800.   PMCID: PMC2847068 [Available on 2011/4/1]
Engstrom PF, Arnoletti JP, Benson AB, Chen YJ, Choti MA, Cooper HS, Covey A, Dilawari RA, Early DS, Enzinger PC, Fakih MG, Fleshman J, Fuchs C, Grem JL, Kiel K, Knol JA, Leong LA, Lin E, Mulcahy MF, Rao S, Ryan DP, Saltz L, Shibata D, Skibber JM, Sofocleous C, Thomas J, Venook AP, Willett C. Colon Cancer. Journal of the National Comprehensive Cancer Network. 2009 Sep;7(8):778-831.   PMCID: no NIH - Practice Guideline
Engstrom PF, Arnoletti JP, Benson AB, Chen YJ, Choti MA, Cooper HS, Covey A, Dilawari RA, Early DS, Enzinger PC, Fakih MG, Fleshman J, Fuchs C, Grem JL, Kiel K, Knol JA, Leong LA, Lin E, Mulcahy MF, Rao S, Ryan DP, Saltz L, Shibata D, Skibber JM, Sofocleous C, Thomas J, Venook AP, Willett C. Rectal Cancer. Journal of the National Comprehensive Cancer Network. 2009 Sep;7(8):838-81.   PMCID: not NIH funded
Stefanek ME, Andrykowski MA, Lerman C, Manne S, Glanz K, Aacr Behav Sci Task Force; AACR Behav Sci Task Force. Behavioral Oncology and the War on Cancer: Partnering with Biomedicine. Cancer Research. 2009 Sep;69(18):7151-6.
Bell J, Brady MF, Young RC, Lage J, Walker JL, Look KY, Rose GS, Spirtos NM. Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: A Gynecologic Oncology Group study. GYNECOLOGIC ONCOLOGY. 2006 Sep;102(3):432-9.
Langer CJ, Moughan J, Movsas B, Komaki R, Ettinger D, Owen J, Wilson JF. Patterns of care survey (PCS) in lung cancer: how well does current US practice with chemotherapy in the non-metastatic setting follow the literature?. Lung Cancer. 2005 Apr;48(1):93-102.
Camma C, Schepis F, Orlando A, Albanese M, Shahied L, Trevisani F, Andreone P, Craxi A, Cottone M. Transarterial chemoembolization for unresectable hepatocellular carcinoma: Meta-analysis of randomized controlled trials. Radiology. 2002 Jul;224(1):47-54.
Russell AH, Harris J, Rosenberg PJ, Sause WT, Fisher BJ, Hoffman JP, Kraybill WG, Byhardt RW. Anal sphincter conservation for patients with adenocarcinoma of the distal rectum: Long-term results of Radiation Therapy Oncology Group Protocol 89-02. International Journal of Radiation Oncology Biology Physics. 2000 Jan 15;46(2):313-22.
Recht A, Bartelink H, Fourquet A, Fowble B, Harris JR, Kurtz J, McCormick B, Olivotto IA, Rutqvist L, Solin LJ, Yarnold J. Postmastectomy radiotherapy: Questions for the twenty-first century. Journal of Clinical Oncology. 1998 Aug;16(8):2886-9.
Crilley P, Goldstein LJ. Peripheral-Blood Stem-Cell Transplant in Breast-Cancer. Seminars in Oncology. 1995 Jun;22(3):238-49.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term adjuvant chemotherapy

adjuvant chemotherapy chemotherapy cancer therapy carcinoma survival oxaliplatin radiotherapy neoplasm recurrence clinical-trials colorectal-cancer prognostic factors carboplatin leucovorin long-term survival randomized controlled-trial colon-cancer rectal neoplasms fluorouracil physical-activity mastectomy neoadjuvant chemotherapy irinotecan recurrence neoplasm staging patterns phase-iii trial colorectal experience NCCN Clinical Practice Guidelines surgery radiation micrometastases surveillance radiology and radiologists coloanal anastomosis confidence-intervals controlled-trial randomized trial complications induction positive breast-cancer quality of life colony- clinical-trial local excision phase-ii dietary modification trial breast-cancer term follow-up fluorouracil plus leucovorin trials efficacy study ii trial symptomatic treatment quantification stimulating factor RISC data base marker regional prognostic indicator lymph-node micrometastases Performance randomized-trial tumor-suppressor gene locally advanced bladder cancer postoperative comparing cisplatin chemotherapeutic embolization oncology smoking-cessation National Cancer Data Base colon cancer plus mindfulness progenitor cells curative resection messenger-rna cyclophosphamide 5-fluorouracil Gerontologic oncology decision-making Quality Oncology adenocarcinoma concurrent epidemiology oxaliplatin-based pancreaticoduodenectomy patterns of care survey high-dose axillary lymph-nodes Colon cancer early stage EOC morbidity rhoc gtpase prostate-cancer p-32 stage-ii muscle invasive bladder cancer quality-of-life negative node colon cancer hyperfractionated radiation-therapy perineural invasion percutaneous ethanol injection prognostic-significance lung cancer lymph-node metastases older cigarette-smoking growth-factor resistance survivorship embolization locally advanced breast cancer inflammatory breast cancer-survival-multidisciplinary management-prognosis breast cancer breast reconstruction-chemotherapy-NCCN predictive-value functional assessment induction chemotherapy growth-factor receptor age immediate reconstruction end results program high-dose chemotherapy paclitaxel outcomes studies intraarterial expression outcomes cancer-related fatigue unresectable liver metastases thoracic radiotherapy chemoradiation ethiodized oil Community oncology colostomy time autologous bone-marrow randomized-trials tumor-cells managing cancer colorectal liver metastases randomized gene-expression signature lipiodol improvement womens health circumferential resection margin adjuvant iii
Last updated on Wednesday, February 05, 2020